Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opiranserin for postoperative pain following laparoscopic colectomy
NCT05764525Phase 3Completed
- Sponsor
- Vivozon
- Start
- Jul 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of opiranserin in postoperative pain, sponsored by Vivozon. Started Jul 2021; status: completed.
02
Drugs
opiranserin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05764525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05764525.